Engkang, Humaydi A.

HRN: 22-34-70  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2022
CEFUROXIME 1.5GM (VIAL)
12/19/2022
12/26/2022
IV
1.5g
Q8H
Fistula In Ano
Waiting Final Action 
12/19/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/19/2022
12/26/2022
IV
500mg
Q8H
Fistula In Ano
Waiting Final Action 
12/21/2022
FLUCONAZOLE 150MG (CAP)
12/21/2022
01/03/2023
PO
150mg
OD
Oral Candidiasis
Waiting Final Action 
12/22/2022
CEFTRIAXONE 1G (VIAL)
12/22/2022
12/28/2022
IV
2g
OD
Syphilis Late Latent
Waiting Final Action 
12/22/2022
BENZYL PENICILLIN 5MU (VIAL)
12/22/2022
12/25/2022
INTRAMUSCULAR
2.4 MU
4x Weekly
Immunocompromised, Syphilis, Fistula In Ano
Waiting Final Action 
12/25/2022
METRONIDAZOLE 500MG (TAB)
12/25/2022
01/01/2023
PO
500mg
TID
Fistula In Ano
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: